E Fund Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$705K Buy
+1,347
New +$644K 0.02% 219
2025
Q2
$829K Sell
2,739
-56
-2% -$16.7K 0.04% 185
2025
Q1
$926K Buy
2,795
+440
+19% +$145K 0.04% 177
2024
Q4
$727K Sell
2,355
-508
-18% -$143K 0.04% 182
2024
Q3
$608K Buy
2,863
+651
+29% +$167K 0.03% 180
2024
Q2
$620K Buy
2,212
+514
+30% +$122K 0.03% 158
2024
Q1
$453K Sell
1,698
-608
-26% -$143K 0.03% 171
2023
Q4
$534K Sell
2,306
-21
-0.9% -$3.67K 0.03% 148
2023
Q3
$340K Buy
2,327
+644
+38% +$121K 0.03% 196
2023
Q2
$389K Buy
1,683
+84
+5% +$22.8K 0.03% 180
2023
Q1
$387K Sell
1,599
-3,933
-71% -$1.07M 0.03% 177
2022
Q4
$1.61M Buy
5,532
+994
+22% +$97.2K 0.13% 66
2022
Q3
$295K Buy
4,538
+968
+27% +$67.3K 0.03% 241
2022
Q2
$256K Buy
3,570
+1,248
+54% +$91.7K 0.02% 259
2022
Q1
$228K Buy
+2,322
New +$196K 0.01% 271

Other funds holding MDGL